MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice
- PMID: 26728044
- PMCID: PMC4700747
- DOI: 10.1186/s12885-015-2007-1
MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice
Abstract
Background: Hepatocellular carcinoma (HCC) is the most common malignant tumor of the liver. Non-alcoholic fatty liver disease (NAFLD) is a frequent chronic liver disorder in developed countries. NAFLD can progress through the more severe non alcoholic steatohepatitis (NASH), cirrhosis and, lastly, HCC. Genetic and epigenetic alterations of coding genes as well as deregulation of microRNAs (miRNAs) activity play a role in HCC development. In this study, the C57BL/6J mouse model was long term high-fat (HF) or low-fat (LF) diet fed, in order to analyze molecular mechanisms responsible for the hepatic damage progression.
Methods: Mice were HF or LF diet fed for different time points, then plasma and hepatic tissues were collected. Histological and clinical chemistry assays were performed to assess the progression of liver disease. MicroRNAs' differential expression was evaluated on pooled RNAs from tissues, and some miRNAs showing dysregulation were further analyzed at the individual level.
Results: Cholesterol, low and high density lipoproteins, triglycerides and alanine aminotransferase increase was detected in HF mice. Gross anatomical examination revealed hepatomegaly in HF livers, and histological analysis highlighted different degrees and levels of steatosis, inflammatory infiltrate and fibrosis in HF and LF animals, demonstrating the progression from NAFLD through NASH. Macroscopic nodules, showing typical neoplastic features, were observed in 20% of HF diet fed mice. Fifteen miRNAs differentially expressed in HF with respect to LF hepatic tissues during the progression of liver damage, and in tumors with respect to HF non tumor liver specimens were identified. Among them, miR-340-5p, miR-484, miR-574-3p, miR-720, whose expression was never described in NAFLD, NASH and HCC tissues, and miR-125a-5p and miR-182, which showed early and significant dysregulation in the sequential hepatic damage process.
Conclusions: In this study, fifteen microRNAs which were modulated in hepatic tissues and in tumors during the transition NAFLD-NASH-HCC are reported. Besides some already described, new and early dysregulated miRNAs were identified. Functional analyses are needed to validate the results here obtained, and to better define the role of these molecules in the progression of the hepatic disease.
Figures






Similar articles
-
Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.J Transl Med. 2015 Jun 16;13:193. doi: 10.1186/s12967-015-0552-7. J Transl Med. 2015. PMID: 26077675 Free PMC article.
-
MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes.Hepatology. 2019 Oct;70(4):1150-1167. doi: 10.1002/hep.30645. Epub 2019 Jun 5. Hepatology. 2019. PMID: 30964207 Free PMC article.
-
Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.Int J Exp Pathol. 2017 Aug;98(4):221-233. doi: 10.1111/iep.12240. Epub 2017 Sep 12. Int J Exp Pathol. 2017. PMID: 28895242 Free PMC article.
-
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539. World J Gastroenterol. 2014. PMID: 25400438 Free PMC article. Review.
-
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.Int J Mol Sci. 2020 Feb 23;21(4):1525. doi: 10.3390/ijms21041525. Int J Mol Sci. 2020. PMID: 32102237 Free PMC article. Review.
Cited by
-
Berberine prevents non-alcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in mice.Am J Transl Res. 2019 May 15;11(5):2668-2682. eCollection 2019. Am J Transl Res. 2019. PMID: 31217846 Free PMC article.
-
Effect of liver fatty acid binding protein (L-FABP) gene ablation on lipid metabolism in high glucose diet (HGD) pair-fed mice.Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jul;1864(7):985-1004. doi: 10.1016/j.bbalip.2019.03.009. Epub 2019 Mar 22. Biochim Biophys Acta Mol Cell Biol Lipids. 2019. PMID: 30910689 Free PMC article.
-
miRNAs in non-alcoholic fatty liver disease.Front Med. 2016 Dec;10(4):389-396. doi: 10.1007/s11684-016-0468-5. Epub 2016 Dec 23. Front Med. 2016. PMID: 27680976 Review.
-
Primate fetal hepatic responses to maternal obesity: epigenetic signalling pathways and lipid accumulation.J Physiol. 2018 Dec;596(23):5823-5837. doi: 10.1113/JP275422. Epub 2018 Apr 6. J Physiol. 2018. PMID: 29516496 Free PMC article.
-
P7TP3 inhibits tumor development, migration, invasion and adhesion of liver cancer through the Wnt/β-catenin signaling pathway.Cancer Sci. 2020 Mar;111(3):994-1007. doi: 10.1111/cas.14243. Epub 2020 Feb 13. Cancer Sci. 2020. PMID: 31746531 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous